COGT
Cogent Biosciences Inc
31.40$
-3.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -205.2% | – | – | – | – | – | – | – | – | – | |
| – | +363.7% | +41.1% | +12.8% | -2.1% | -44.3% | -79.6% | +3,898.6% | -39.0% | +21.3% | +5.3% | |
| – | +309.7% | +32.0% | +130.3% | +5.0% | +85.7% | +94.2% | +57.2% | +66.7% | +29.8% | +16.0% | |
| – | – | – | – | – | +1,300.5% | -73.2% | +57.2% | – | – | – | |
| – | -109.7% | – | – | – | – | – | -62.8% | +1,423.6% | +1.3% | -30.9% | |
| – | +65.8% | -72.4% | -39.8% | -94.0% | +869.7% | +437.2% | +299.2% | -59.3% | -79.5% | +171.2% | |
| – | +836.6% | – | -177.9% | – | -63.6% | -120.4% | +7,155.3% | -21.6% | – | -1,143.8% | |
| – | – | – | – | – | – | -100.0% | +2,832.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.1% | +1,722.5% | – | -99.8% | +214,896.3% | -83.6% | +330.7% | 0.0% | +31.1% | +309.5% | |
| – | -157.6% | – | – | -166.8% | – | -111.0% | – | – | – | +376.8% | |
| – | -239.6% | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.